Cardiometabolic and Lipids
- Yes
MASLD and MASH: Early Identification to Decrease Associated Complications
CME : 2 | 2 : ABIM-MOC
Starts: 8/19/2024 | Expires: 8/19/2025
Access our FREE online course designed to equip healthcare professionals with the latest knowledge and tools to effectively identify and manage patients at risk for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Clinical Guidance
2025 Clinical Practice Guideline for the Pharmacologic Management of Adults with Dyslipidemia
This guideline was developed by a multidisciplinary task force and uses the GRADE framework to provide evidence-based recommendations regarding cardiovascular risk assessment, benefits and harms of newer medications, and treatment goals with a focus on patient-important outcomes.
AvoMD Integrates AACE Clinical Guidance
AvoMD, a software platform that brings clinical evidence into the workflow to help clinicians streamline decisions and save time, has partnered with AACE to integrate clinical guidance documents into the AvoMD platform.
2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
This guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders.